c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function

International Immunology

Volumn 11, Issue 3, 1999, Pages 361-371

  Liou, Hsiou Chi ^a   Jin, Zhuang ^a   Tumang, Joseph ^a   Andjelic, Sofija ^a   Smith, Kendall A ^a   Liou, Mei Ling ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

c Rel; Lymphocyte; Proliferation; T cell

Indexed keywords

ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 3; MITOGENIC AGENT; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; GENE EXPRESSION REGULATION; GENE MUTATION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0033023431     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.3.361     Document Type: Article

References (56)

1. Sen, R. and Baltimore, D. 1986. Multiple nuclear factors interact with the immunoglobulin enhancers. Cell 46:705.
2. Baeuerle, P. A. and Baltimore, D. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540.
3. Lenardo, M. J. and Baltimore, D. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227.
4. Ghosh, S., et al. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019.
5. Nolan, G. P., Ghosh, S., Liou, H.-C., Tempst, P. and Baltimore, D. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961.
6. Liou, H.-C. and Baltimore, D. 1993 Regulation of the NF-κB/Rel transcription factor and IκB inhibitor system. Cur. Opin. Cell Biol. 5:477.
7. Fujita, T., Nolan, G. P., Liou, H.-C., Scott, M. L. and Baltimore, D. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional co-activator that activates NF-κB p50 homodimers. Genes Dev. 7:1354.
8. Baeuerle, P. and Baltimore, D. 1996. NF-kB: ten years after. Cell 87:13.
9. Sha, W. C., Liou, H.-C., Tuomanen, E. I. and Baltimore, D. 1995. Targeted disruption of the p50 subunit of NF-kB leads to multifocal defects in immune responses. Cell 80:321.
10. Weih, F., et al. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kB/Rel family. Cell 80:331.
11. Burkly, L., et al. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531.
12. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kB. Nature 376:167.
13. Kontgen, F., et al. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965.
14. Franzoso, G., et al. 1998. Mice deficient in Nuclear Factor (NF)-kB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147.
15. Caamano, J. H., et al. 1998. Nuclear Factor(NF)-kB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185.
16. Liou, H.-C., Sha, W. C., Scott, M. L. and Baltimore, D. 1994. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell Biol. 14:5349.
17. Cantrell, D. A. and Smith, K. A. 1984. The interleukin-2 T-cell system: a new cell growth model. Science 224:1312.
18. 1 progression and c-myb expression. Science 233:203.
19. Wang, W., Tam, W. F., Hughes, C. C., Rath, S. and Sen, R. 1997. c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 6:165.
20. Northrop, J. P., et al. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369:497.
21. Rooney, J. W., Sun, Y. L., Glimcher, L. H. and Hoey, T. 1995. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell Biol. 15:6299.
22. Chen, D. and Rothenberg, E. V. 1994. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179:931.
23. Garrity, P. A., Chen, D., Rothenberg, E. V. and Wold, B. J. 1994. Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol. Cell Biol. 14:2159.
24. Rothenberg, E. V. and Ward, S. B. 1996. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc. Natl Acad. Sci. USA 93:9358.
25. Auphan, N., Di Donato, J. A., Rosette, C., Helmberg, A. and Karin, M. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286.
26. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. and Baldwin, A. S., Jr. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283.
27. Gerondakis, S., et al. 1996. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl Acad. Sci. USA 93:3405.
28. Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T. and Mulligan, R. C. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153.
29. Li, E., Bestor, T. H. and Jaenisch, R. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915.
30. Grilli, M., Chiu, J.-S. and Lenardo, M. J. 1991. NF-κB and rel-participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
31. Tan, T.-H., et al. 1992. κB-site dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-rel. Mol. Cell Biol. 12:4067.
32. John, S., et al. 1995. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol. Cell Biol. 15:1786.
33. Weih, F., Warr, G., Yang, H. and Bravo, R. 1997. Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 158:5211.
34. Pierce, J. W., Jamieson, C. A., Ross, J. L. and Sen, R. 1995. Activation of IL-2 receptor alpha-chain gene by individual members of the rel oncogene family in association with serum response factor. J. Immunol. 155:1972.
35. DeFranco, A. L., Ashwell, J. D., Schwartz, R. H. and Paul, W. E. 1984. Polyclonal stimulation of resting B lymphocytes by antigen-activated T lymphocytes. J. Exp. Med. 159:861.
36. Tumang, J. R., Posnett, D. N., Cole, B. C., Crow, M. and Friedman, S. M. 1990. Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. J. Exp. Med. 171:2153.
37. Tumang, J. R., et al. 1991. T helper cell-dependent microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses. J. Immunol. 147:432.
38. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
39. Clark, L. B., Foy, T. M. and Noelle, R. J. 1996. CD40 and its ligand. Adv. Immunol. 63:43.
40. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity 4:415.
41. June, C H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
42. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A. 1996. CD28/ B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
43. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. and Karin, M. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286.
44. Scheinman, R. I., Cogsell, P. C., Lofquist, A. K. and Baldwin, A. S., Jr. 1995. Role of transcriptional activation of IkBa in mediation of immunosupression by glucocorticoids. Science 270:283.
45. Ray, A. and Prefontaine, K. E. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor Proc. Natl Acad. Sci. USA 91:752.
46. Hodge, M. R., et al. 1996. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4:397.
47. Xanthoudakis, S., et al. 1996. An enhanced immune response in mice lacking the transcription factor NF-AT1. Science 272:892.
48. h2 cytokine production. Immunity 8:115.
49. Ranger, A. M., et al. 1998. Delayed lymphoid repopulation with defects in II-4-driven responses produced by inactivation of NF-ATc. Immunity 8:125.
50. Chen, L., Glover, J. N. M., Hogan, P. G., Rao, A. and Harrision, S. C. 1998. Structure of the DNA-binding domains from NF-AT, Fos, and Jun bound to DNA. Nature 392:42.
51. Lederer, J. A., Liou, J. S., Todd, M. D., Glimcher, L. H. and Lichtman, A. H. 1994. Regulation of cytokine gene expression in T helper cell subsets. J. Immunol. 152:77.
52. Timmerman, L. A., et al. 1997. Redundant expression but selective utilization of nuclear factor of activated T cells family members. J. Immunol. 159:2735.
53. Rooney, J. W., Hoey, T. and Glimcher, L. H. 1995. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 2:473.
54. Smith, K. A. and Cantrell, D. A. 1985. Interleukin 2 regulates its own receptors. Proc. Natl Acad. Sci. USA 82:864.
55. John, S., Robbins, C. M. and Leonard, W. J. 1996. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 15:5627.
56. Berke, G. and Rosen, D. 1988. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro. J. Immunol. 141:1429.